Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPWR
1776
DELISTED
SunPower Corporation Common Stock
SPWR
| $7.46M | ﹤0.01% |
1,276,370
+154,393
| +14% | +$1.2M |
|
|
ESV
1777
DELISTED
Ensco Rowan plc
ESV
| $7.45M | ﹤0.01% |
219,189
+66,343
| +43% | +$2.26M |
|
1778
PUT
Rockwell Automation
ROK
$47.9B
| $7.44M | ﹤0.01% |
60,800
-44,400
| -42% | -$5.19M |
|
|
THS
1779
CALL
DELISTED
Treehouse Foods
THS
| $7.44M | ﹤0.01% |
85,300
-13,200
| -13% | -$1.27M |
|
1780
Post Holdings
POST
$3.72B
| $7.43M | ﹤0.01% |
+147,218
| New | +$8.08M |
|
1781
PUT
Antero Resources
AR
$11.8B
| $7.43M | ﹤0.01% |
275,800
+34,400
| +14% | +$916K |
|
1782
JetBlue
JBLU
$1.88B
| $7.41M | ﹤0.01% |
429,696
+124,748
| +41% | +$2.13M |
|
|
RDUS
1783
DELISTED
Radius Health, Inc.
RDUS
| $7.39M | ﹤0.01% |
+136,611
| New | +$6.94M |
|
1784
PUT
iShares S&P 100 ETF
OEF
$20.3B
| $7.39M | ﹤0.01% |
77,000
+42,800
| +125% | +$4.11M |
|
1785
PUT
Idexx Laboratories
IDXX
$43.6B
| $7.38M | ﹤0.01% |
65,500
+36,600
| +127% | +$3.86M |
|
1786
PUT
Analog Devices
ADI
$180B
| $7.38M | ﹤0.01% |
114,500
+90,300
| +373% | +$5.6M |
|
1787
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.09B
| $7.38M | ﹤0.01% |
154,356
+115,364
| +296% | +$5.41M |
|
1788
PUT
iShares Semiconductor ETF
SOXX
$42B
| $7.36M | ﹤0.01% |
195,300
-23,700
| -11% | -$827K |
|
1789
Markel Group
MKL
$22.5B
| $7.35M | ﹤0.01% |
7,916
-10,378
| -57% | -$9.68M |
|
|
ETFC
1790
PUT
DELISTED
E*Trade Financial Corporation
ETFC
| $7.35M | ﹤0.01% |
252,400
+25,100
| +11% | +$649K |
|
|
CEO
1791
DELISTED
CNOOC Limited
CEO
| $7.34M | ﹤0.01% |
58,000
| – | – |
|
|
USG
1792
CALL
DELISTED
Usg
USG
| $7.33M | ﹤0.01% |
283,700
-30,500
| -10% | -$847K |
|
1793
PUT
Banc of California
BANC
$2.98B
| $7.32M | ﹤0.01% |
419,300
+395,500
| +1,662% | +$8.21M |
|
|
OCLR
1794
CALL
DELISTED
Oclaro Inc.
OCLR
| $7.32M | ﹤0.01% |
856,000
+742,200
| +652% | +$5.16M |
|
|
WBMD
1795
CALL
DELISTED
WebMD Health Corp.
WBMD
| $7.32M | ﹤0.01% |
147,200
+100,000
| +212% | +$5.52M |
|
|
1796
CALL
iShares S&P 100 ETF
OEF
$20.3B
| $7.29M | ﹤0.01% |
76,000
-24,200
| -24% | -$2.32M |
|
1797
PUT
PVH
PVH
$3.62B
| $7.27M | ﹤0.01% |
65,800
-40,000
| -38% | -$4.14M |
|
1798
CALL
Cullen/Frost Bankers
CFR
$10.1B
| $7.27M | ﹤0.01% |
101,000
-3,300
| -3% | -$228K |
|
1799
TAL Education Group
TAL
$6.48B
| $7.26M | ﹤0.01% |
614,940
+265,950
| +76% | +$2.8M |
|
1800
CALL
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$25.9M
| $7.26M | ﹤0.01% |
15
+13
| +650% | +$6.59M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.